Atea Pharmaceuticals Inc (AVIR)

08:00 AM

ReAlta Life Sciences (AVIR) appoints Dr. Howard Berman as Executive Chairman - Stock Titan

08:00 AM

Nov 21, 2025

Will Atea Pharmaceuticals Inc. stock beat EPS estimatesTrade Risk Report & Expert Approved Momentum Trade Ideas - newser.com

Nov 21, 2025

Nov 20, 2025

Is Atea Pharmaceuticals Inc. stock reversal real or fake2025 Winners & Losers & Technical Pattern Based Buy Signals - newser.com

Nov 20, 2025

Nov 20, 2025

Will Atea Pharmaceuticals Inc. stock outperform growth indexesJuly 2025 Action & Momentum Based Trading Ideas - newser.com

Nov 20, 2025

Nov 20, 2025

How strong is Atea Pharmaceuticals Inc. stock revenue growth2025 Historical Comparison & Growth Focused Investment Plans - newser.com

Nov 20, 2025

Nov 19, 2025

Atea Pharmaceuticals Inc (AVIR) Q3 2025 Earnings Call Highlights: Strategic Advances in HCV ... By GuruFocus - Investing.com Canada

Nov 19, 2025

Nov 19, 2025

Atea Pharma (NASDAQ: AVIR) hosts Evercore fireside chat Dec. 3 at 10:00 a.m. ET - Stock Titan

Nov 19, 2025

Nov 19, 2025

Is a relief rally coming for Atea Pharmaceuticals Inc. holdersProduct Launch & High Return Trade Opportunity Guides - newser.com

Nov 19, 2025

Nov 18, 2025

How Atea Pharmaceuticals Inc. stock performs in rate cut cyclesQuarterly Earnings Summary & Reliable Intraday Trade Alerts - newser.com

Nov 18, 2025

Nov 17, 2025

Atea Pharma (AVIR) Earnings Call Transcript - AOL.com

Nov 17, 2025

Nov 17, 2025

William Blair Has Negative Outlook of AVIR FY2025 Earnings - Defense World

Nov 17, 2025

Nov 16, 2025

Atea Pharmaceuticals Inc. stock trend outlook and recovery pathMarket Growth Report & Reliable Price Action Trade Plans - newser.com

Nov 16, 2025

Nov 16, 2025

Live market analysis of Atea Pharmaceuticals Inc.CEO Change & AI Enhanced Market Trend Forecasts - newser.com

Nov 16, 2025

Nov 15, 2025

Backtesting results for Atea Pharmaceuticals Inc. trading strategiesJuly 2025 Summary & Real-Time Market Sentiment Reports - newser.com

Nov 15, 2025

Nov 15, 2025

Atea Pharmaceuticals’ Earnings Call Highlights Progress and Optimism - MSN

Nov 15, 2025

Nov 15, 2025

Key metrics from Atea Pharmaceuticals Inc.’s quarterly dataMarket Trend Report & Fast Moving Stock Trade Plans - newser.com

Nov 15, 2025

Nov 14, 2025

What Makes HDFC Mutual fund a Strong Contender in YEAREarnings Call Summaries & Fast Growing Portfolio - earlytimes.in

Nov 14, 2025

Nov 14, 2025

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 14, 2025

Nov 14, 2025

Atea Pharmaceuticals, Inc. 2025 Q3ResultsEarnings Call Presentation (NASDAQ:AVIR) 2025-11-14 - Seeking Alpha

Nov 14, 2025

Nov 12, 2025

Atea Pharmaceuticals Advances Antiviral Programs with New Data - TipRanks

Nov 12, 2025

Nov 12, 2025

Atea Pharmaceuticals Q3 2025 Earnings Call Transcript - MarketBeat

Nov 12, 2025

Nov 12, 2025

Earnings call transcript: Atea Pharmaceuticals Q3 2025 sees EPS miss By Investing.com - Investing.com Nigeria

Nov 12, 2025

Nov 12, 2025

Earnings call transcript: Atea Pharmaceuticals Q3 2025 sees EPS miss - Investing.com

Nov 12, 2025

Nov 12, 2025

Atea Pharmaceuticals, Inc. SEC 10-Q Report - TradingView

Nov 12, 2025

Nov 12, 2025

Atea Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener

Nov 12, 2025

Nov 12, 2025

[10-Q] Atea Pharmaceuticals, Inc. Quarterly Earnings Report | AVIR SEC FilingForm 10-Q - Stock Titan

Nov 12, 2025

Nov 12, 2025

Atea Pharmaceuticals, Inc. (AVIR) Q3 FY2025 earnings call transcript - Yahoo Finance

Nov 12, 2025

Nov 12, 2025

Atea Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update - The Manila Times

Nov 12, 2025

Nov 12, 2025

Atea Pharmaceuticals : Q3 Slides November 12 2025 FINAL - MarketScreener

Nov 12, 2025

Nov 12, 2025

[8-K] Atea Pharmaceuticals, Inc. Reports Material Event | AVIR SEC FilingForm 8-K - Stock Titan

Nov 12, 2025

Nov 12, 2025

Atea (Nasdaq: AVIR) says HCV Phase 3 on track; C-BEYOND topline results mid-2026 - Stock Titan

Nov 12, 2025